Novartis announced a restructuring plan yesterday which involves cutting between 400 - 440 development jobs in Switzerland over the next few years.
Another 240 jobs are at risk in the USA.
The Basel-based pharmaceutical company currently employs over 10’000 people, around 3’000 of whom are dedicated to development.
The company, which is consistently ranked as one of the global top 5 pharmaceutical companies in the world, insists that its research activities will remain unaffected.
Swiss hospitals on alert after devastating resort fire
Guilty of rape, jailed - then deported
US tarrifs cut - for now
School student accused of Twint theft
Yet another scam to be careful of
Injuries over Xmas soar
